145 related articles for article (PubMed ID: 24790623)
1. Effect of tissue composition on dose distribution in brachytherapy with various photon emitting sources.
Ghorbani M; Salahshour F; Haghparast A; Moghaddas TA; Knaup C
J Contemp Brachytherapy; 2014 Mar; 6(1):54-67. PubMed ID: 24790623
[TBL] [Abstract][Full Text] [Related]
2. Tissue composition effect on dose distribution in neutron brachytherapy/neutron capture therapy.
Khosroabadi M; Farhood B; Ghorbani M; Hamzian N; Moghaddam HR; Davenport D
Rep Pract Oncol Radiother; 2016; 21(1):8-16. PubMed ID: 26900352
[TBL] [Abstract][Full Text] [Related]
3. [Simulation of dose distribution in bone medium of
Ye KQ; Huang MW; Li JL; Tang JT; Zhang JG
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):131-135. PubMed ID: 29483735
[TBL] [Abstract][Full Text] [Related]
4. Dose to tissue medium or water cavities as surrogate for the dose to cell nuclei at brachytherapy photon energies.
Enger SA; Ahnesjö A; Verhaegen F; Beaulieu L
Phys Med Biol; 2012 Jul; 57(14):4489-500. PubMed ID: 22722477
[TBL] [Abstract][Full Text] [Related]
5. Determination of TG-43 Dosimetric Parameters for Photon Emitting Brachytherapy Sources.
A M; M G
J Biomed Phys Eng; 2019 Aug; 9(4):425-436. PubMed ID: 31531295
[TBL] [Abstract][Full Text] [Related]
6. Dependence of Yb-169 absorbed dose energy correction factors on self-attenuation in source material and photon buildup in water.
Medich DC; Munro JJ
Med Phys; 2010 May; 37(5):2135-44. PubMed ID: 20527547
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison between the microSelectron HDR (192)Ir v2 source and the BEBIG (60)Co source for HDR brachytherapy using the EGSnrc Monte Carlo transport code.
Islam MA; Akramuzzaman MM; Zakaria GA
J Med Phys; 2012 Oct; 37(4):219-25. PubMed ID: 23293454
[TBL] [Abstract][Full Text] [Related]
8. Detailed analysis of dose difference in using water as tissue-equivalent material in
Gholamhossein IV; Firoozabadi Mohammad M; Mahdi G
Rep Pract Oncol Radiother; 2019; 24(6):660-666. PubMed ID: 31719804
[TBL] [Abstract][Full Text] [Related]
9. A Monte Carlo evaluation of dose enhancement by cisplatin and titanocene dichloride chemotherapy drugs in brachytherapy with photon emitting sources.
Yahya Abadi A; Ghorbani M; Mowlavi AA; Knaup C
Australas Phys Eng Sci Med; 2014 Jun; 37(2):327-36. PubMed ID: 24706342
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo dosimetry for a new
Rajabi R; Taherparvar P
J Contemp Brachytherapy; 2019 Feb; 11(1):76-90. PubMed ID: 30911314
[TBL] [Abstract][Full Text] [Related]
11. Photon activation therapy: a Monte Carlo study on dose enhancement by various sources and activation media.
Bakhshabadi M; Ghorbani M; Meigooni AS
Australas Phys Eng Sci Med; 2013 Sep; 36(3):301-11. PubMed ID: 23934379
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
13. Effect of photon energy spectrum on dosimetric parameters of brachytherapy sources.
Ghorbani M; Mehrpouyan M; Davenport D; Ahmadi Moghaddas T
Radiol Oncol; 2016 Jun; 50(2):238-46. PubMed ID: 27247558
[TBL] [Abstract][Full Text] [Related]
14. A Monte Carlo study on dose distribution evaluation of Flexisource (192)Ir brachytherapy source.
Alizadeh M; Ghorbani M; Haghparast A; Zare N; Ahmadi Moghaddas T
Rep Pract Oncol Radiother; 2015; 20(3):204-9. PubMed ID: 25949224
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
16. The difference of scoring dose to water or tissues in Monte Carlo dose calculations for low energy brachytherapy photon sources.
Landry G; Reniers B; Pignol JP; Beaulieu L; Verhaegen F
Med Phys; 2011 Mar; 38(3):1526-33. PubMed ID: 21520864
[TBL] [Abstract][Full Text] [Related]
17. On the feasibility of polyurethane based 3D dosimeters with optical CT for dosimetric verification of low energy photon brachytherapy seeds.
Adamson J; Yang Y; Juang T; Chisholm K; Rankine L; Adamovics J; Yin FF; Oldham M
Med Phys; 2014 Jul; 41(7):071705. PubMed ID: 24989374
[TBL] [Abstract][Full Text] [Related]
18. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
Melhus CS; Rivard MJ
Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
[TBL] [Abstract][Full Text] [Related]
19. A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles.
Bahreyni Toossi MT; Ghorbani M; Mehrpouyan M; Akbari F; Sobhkhiz Sabet L; Soleimani Meigooni A
Australas Phys Eng Sci Med; 2012 Jun; 35(2):177-85. PubMed ID: 22700179
[TBL] [Abstract][Full Text] [Related]
20. A comparison study on various low energy sources in interstitial prostate brachytherapy.
Bakhshabadi M; Ghorbani M; Khosroabadi M; Knaup C; Meigooni AS
J Contemp Brachytherapy; 2016 Feb; 8(1):74-81. PubMed ID: 26985200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
